Skip to main content
. Author manuscript; available in PMC: 2018 Aug 14.
Published in final edited form as: Ann Surg Oncol. 2017 Mar 3;24(7):1965–1971. doi: 10.1245/s10434-017-5816-4

TABLE 4.

Bivariate progression-free survival model

Variable Levels HR (95% CI) p value
SLN Yes versus no 0.97 (0.62–1.51) 0.894
Stage III/IV versus I/II 3.64 (2.36–5.61) <0.001

SLN sentinel lymph node, HR hazard ratio, CI confidence interval